ZEAL:CPH
Zealand Pharma A/S
DKKÂ 305.40
arrow_downward
-1.64%(-5.10) 1D
Sep 4, 5:00:00 PM GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ZEAL...
Open
DKKÂ 313.00
High
DKKÂ 317.20
Low
DKKÂ 305.40
Mkt. cap
22.23B
Avg. vol.
363.44K
Volume
303.97K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 233.50
Shares outstanding
71.58M
No. of employees
578
Open
DKKÂ 313.00
High
DKKÂ 317.20
Low
DKKÂ 305.40
Mkt. cap
22.23B
Avg. vol.
363.44K
Volume
303.97K
52-wk high
DKKÂ 556.00
52-wk low
DKKÂ 233.50
Shares outstanding
71.58M
No. of employees
578
News stories
From web sources and news partners
Yahoo Finance
·
2 days ago
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A/S
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com